EDEN PRAIRIE, Minn.,
July 28, 2021 /PRNewswire/ --
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (NeuroOne
or the Company), a medical technology company focused on improving
surgical care options and outcomes for patients suffering from
neurological disorders, announces today that the Company will
participate in Alliance Global Partners (A.G.P.) Virtual MedTech
Summer Conference on July 29,
2021.
The event will consist of one-on-one virtual investor meetings.
Investors participating in the virtual conference who are
interested in meeting with management should contact their A.G.P.
representative or James@HaydenIR.com .
About NeuroOne
NeuroOne Medical Technologies Corporation is a developmental
stage company committed to providing minimally invasive and
hi-definition solutions for EEG recording, brain stimulation and
ablation solutions for patients suffering from epilepsy,
Parkinson's disease, dystonia, essential tremors, chronic pain due
to failed back surgeries and other related neurological disorders
that may improve patient outcomes and reduce procedural costs. For
more information,
visit https://www.n1mtc.com.
The Company previously announced it had successfully met the
first performance milestone in the distribution and development
agreement signed with Zimmer Biomet on July 20, 2020. In
addition to acquiring exclusive global distribution rights to
NeuroOne's Evo™ (Evo) patented electrode technology,
the partnership also offered the potential for NeuroOne to earn
back-end milestone payments if certain events were met within a
specified time frame.
NeuroOne received FDA clearance for its Evo cortical technology
in November 2019.
In partnership with Mayo Clinic, Wisconsin Alumni Research
Foundation (WARF) and other prominent academic medical centers, the
Company began developing its cortical electrode technology in 2015.
The Company initially focused its efforts on the epilepsy and
intraoperative tumor monitoring markets. NeuroOne intends to
continue to develop the technology for use in therapeutic
applications for Parkinson's disease, epilepsy and pain management
due to failed back surgery procedures.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neuroone-to-participate-in-alliance-global-partners-agp-virtual-medtech-summer-conference-on-july-29-2021-301342767.html
SOURCE NeuroOne Medical Technologies Corporation